Home > > > Report Detail

Global Age Related Macular Degeneration Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 30-Aug-2022
No. of pages: 107
Inquire Before Buying

Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for "straight-ahead" activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Age Related Macular Degeneration Drug market is projected to reach US$ 11590 million by 2028 from an estimated US$ 8220.3 million in 2022, at a CAGR of 5.9% during 2023 and 2028.

North America is the largest Age Related Macular Degeneration Drug market with about 65% market share. Europe is follower, accounting for about 29% market share.

The key players are Regeneron Pharmaceuticals, Bayer HealthCare, Novartis, Roche, Kanghong Pharma etc. Top 3 companies occupied about 79% market share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Age Related Macular Degeneration Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Age Related Macular Degeneration Drug.

The Age Related Macular Degeneration Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Age Related Macular Degeneration Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Age Related Macular Degeneration Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Regeneron Pharmaceuticals

- Bayer HealthCare

- Novartis

- Roche

- Kanghong Pharma

Product Type Insights

Global markets are presented by Age Related Macular Degeneration Drug type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Age Related Macular Degeneration Drug are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Age Related Macular Degeneration Drug Segment by Type

- Lucentis

- Eylea

- Avastin

- Others

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Age Related Macular Degeneration Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Age Related Macular Degeneration Drug market.

Age Related Macular Degeneration Drug Segment by Application

- Hospitals

- Clinics

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Age Related Macular Degeneration Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Age Related Macular Degeneration Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Age Related Macular Degeneration Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Age Related Macular Degeneration Drug industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Age Related Macular Degeneration Drug

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Age Related Macular Degeneration Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Age Related Macular Degeneration Drug Product Introduction
1.2 Market by Type
1.2.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Age Related Macular Degeneration Drug Market Size Estimates and Forecasts
2.1.1 Global Age Related Macular Degeneration Drug Revenue 2017-2028
2.1.2 Global Age Related Macular Degeneration Drug Sales 2017-2028
2.2 Age Related Macular Degeneration Drug Market Size by Region: 2022 Versus 2028
2.3 Age Related Macular Degeneration Drug Sales by Region (2017-2028)
2.3.1 Global Age Related Macular Degeneration Drug Sales by Region: 2017-2022
2.3.2 Global Age Related Macular Degeneration Drug Sales Forecast by Region (2023-2028)
2.3.3 Global Age Related Macular Degeneration Drug Sales Market Share by Region (2017-2028)
2.4 Age Related Macular Degeneration Drug Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Age Related Macular Degeneration Drug Revenue by Region: 2017-2022
2.4.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2023-2028)
2.4.3 Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2017-2028)
3 Global Age Related Macular Degeneration Drug by Manufacturers
3.1 Global Top Age Related Macular Degeneration Drug Manufacturers by Sales
3.1.1 Global Age Related Macular Degeneration Drug Sales by Manufacturer (2017-2022)
3.1.2 Global Age Related Macular Degeneration Drug Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Age Related Macular Degeneration Drug Manufacturers by Revenue
3.2.1 Global Age Related Macular Degeneration Drug Revenue by Manufacturer (2017-2022)
3.2.2 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturer (2017-2022)
3.3 Global Age Related Macular Degeneration Drug Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Age Related Macular Degeneration Drug Manufacturers Covered: Ranking by Revenue
3.4.2 Global Age Related Macular Degeneration Drug Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Age Related Macular Degeneration Drug Manufacturing Base Distribution, Product Type
3.5.1 Age Related Macular Degeneration Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Age Related Macular Degeneration Drug Product Type
3.5.3 Date of International Manufacturers Enter into Age Related Macular Degeneration Drug Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Regeneron Pharmaceuticals
4.1.1 Regeneron Pharmaceuticals Corporation Information
4.1.2 Regeneron Pharmaceuticals Description, Business Overview
4.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Products Offered
4.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales by Product in 2021
4.1.6 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales by Application in 2021
4.1.7 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales by Geographic Area in 2021
4.1.8 Regeneron Pharmaceuticals Recent Developments
4.2 Bayer HealthCare
4.2.1 Bayer HealthCare Corporation Information
4.2.2 Bayer HealthCare Description, Business Overview
4.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Products Offered
4.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Bayer HealthCare Age Related Macular Degeneration Drug Sales by Product in 2021
4.2.6 Bayer HealthCare Age Related Macular Degeneration Drug Sales by Application in 2021
4.2.7 Bayer HealthCare Age Related Macular Degeneration Drug Sales by Geographic Area in 2021
4.2.8 Bayer HealthCare Recent Developments
4.3 Novartis
4.3.1 Novartis Corporation Information
4.3.2 Novartis Description, Business Overview
4.3.3 Novartis Age Related Macular Degeneration Drug Products Offered
4.3.4 Novartis Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Novartis Age Related Macular Degeneration Drug Sales by Product in 2021
4.3.6 Novartis Age Related Macular Degeneration Drug Sales by Application in 2021
4.3.7 Novartis Age Related Macular Degeneration Drug Sales by Geographic Area in 2021
4.3.8 Novartis Recent Developments
4.4 Roche
4.4.1 Roche Corporation Information
4.4.2 Roche Description, Business Overview
4.4.3 Roche Age Related Macular Degeneration Drug Products Offered
4.4.4 Roche Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Roche Age Related Macular Degeneration Drug Sales by Product in 2021
4.4.6 Roche Age Related Macular Degeneration Drug Sales by Application in 2021
4.4.7 Roche Age Related Macular Degeneration Drug Sales by Geographic Area in 2021
4.4.8 Roche Recent Developments
4.5 Kanghong Pharma
4.5.1 Kanghong Pharma Corporation Information
4.5.2 Kanghong Pharma Description, Business Overview
4.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Products Offered
4.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Kanghong Pharma Age Related Macular Degeneration Drug Sales by Product in 2021
4.5.6 Kanghong Pharma Age Related Macular Degeneration Drug Sales by Application in 2021
4.5.7 Kanghong Pharma Age Related Macular Degeneration Drug Sales by Geographic Area in 2021
4.5.8 Kanghong Pharma Recent Developments
5 Breakdown Data by Type
5.1 Global Age Related Macular Degeneration Drug Sales by Type (2017-2028)
5.1.1 Global Age Related Macular Degeneration Drug Sales by Type (2017-2022)
5.1.2 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2023-2028)
5.1.3 Global Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2028)
5.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2017-2028)
5.2.1 Global Age Related Macular Degeneration Drug Revenue by Type (2017-2022)
5.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2023-2028)
5.2.3 Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2017-2028)
5.3 Age Related Macular Degeneration Drug Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Age Related Macular Degeneration Drug Sales by Application (2017-2028)
6.1.1 Global Age Related Macular Degeneration Drug Sales by Application (2017-2022)
6.1.2 Global Age Related Macular Degeneration Drug Sales Forecast by Application (2023-2028)
6.1.3 Global Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2028)
6.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2017-2028)
6.2.1 Global Age Related Macular Degeneration Drug Revenue by Application (2017-2022)
6.2.2 Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2023-2028)
6.2.3 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2017-2028)
6.3 Age Related Macular Degeneration Drug Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Age Related Macular Degeneration Drug Market Size YoY Growth 2017-2028
7.2 North America Age Related Macular Degeneration Drug Market Facts & Figures by Country
7.2.1 North America Age Related Macular Degeneration Drug Sales by Country (2017-2028)
7.2.2 North America Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
7.3 North America Age Related Macular Degeneration Drug Sales by Type
7.4 North America Age Related Macular Degeneration Drug Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Age Related Macular Degeneration Drug Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Age Related Macular Degeneration Drug Market Facts & Figures by Region
8.2.1 Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2017-2028)
8.2.2 Asia-Pacific Age Related Macular Degeneration Drug Revenue by Region (2017-2028)
8.3 Asia-Pacific Age Related Macular Degeneration Drug Sales by Type
8.4 Asia-Pacific Age Related Macular Degeneration Drug Sales by Application
9 Europe
9.1 Europe Age Related Macular Degeneration Drug Market Size YoY Growth 2017-2028
9.2 Europe Age Related Macular Degeneration Drug Market Facts & Figures by Country
9.2.1 Europe Age Related Macular Degeneration Drug Sales by Country (2017-2028)
9.2.2 Europe Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
9.3 Europe Age Related Macular Degeneration Drug Sales by Type
9.4 Europe Age Related Macular Degeneration Drug Sales by Application
10 Latin America
10.1 Latin America Age Related Macular Degeneration Drug Market Size YoY Growth 2017-2028
10.2 Latin America Age Related Macular Degeneration Drug Market Facts & Figures by Country
10.2.1 Latin America Age Related Macular Degeneration Drug Sales by Country (2017-2028)
10.2.2 Latin America Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
10.3 Latin America Age Related Macular Degeneration Drug Sales by Type
10.4 Latin America Age Related Macular Degeneration Drug Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Age Related Macular Degeneration Drug Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Age Related Macular Degeneration Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2017-2028)
11.2.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
11.3 Middle East and Africa Age Related Macular Degeneration Drug Sales by Type
11.4 Middle East and Africa Age Related Macular Degeneration Drug Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Age Related Macular Degeneration Drug Supply Chain Analysis
12.2 Age Related Macular Degeneration Drug Key Raw Materials and Upstream Suppliers
12.3 Age Related Macular Degeneration Drug Clients Analysis
12.4 Age Related Macular Degeneration Drug Sales Channel and Sales Model Analysis
12.4.1 Age Related Macular Degeneration Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Age Related Macular Degeneration Drug Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Age Related Macular Degeneration Drug Distributors
13 Market Dynamics
13.1 Age Related Macular Degeneration Drug Industry Trends
13.2 Age Related Macular Degeneration Drug Market Drivers
13.3 Age Related Macular Degeneration Drug Market Challenges
13.4 Age Related Macular Degeneration Drug Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Age Related Macular Degeneration Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Lucentis
Table 3. Major Manufacturers of Eylea
Table 4. Major Manufacturers of Avastin
Table 5. Major Manufacturers of Others
Table 6. Global Age Related Macular Degeneration Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Age Related Macular Degeneration Drug Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 8. Global Age Related Macular Degeneration Drug Sales by Region (2017-2022) & (K Units)
Table 9. Global Age Related Macular Degeneration Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 10. Global Age Related Macular Degeneration Drug Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Age Related Macular Degeneration Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 12. Global Age Related Macular Degeneration Drug Sales by Manufacturer (2017-2022) & (K Units)
Table 13. Global Age Related Macular Degeneration Drug Sales Share by Manufacturer (2017-2022)
Table 14. Age Related Macular Degeneration Drug Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 15. Age Related Macular Degeneration Drug Revenue Share by Manufacturer (2017-2022)
Table 16. Key Manufacturers Age Related Macular Degeneration Drug Price (2017-2022) & (USD/Unit)
Table 17. Ranking of Global Top Age Related Macular Degeneration Drug Manufacturers by Revenue (US$ Million) in 2021
Table 18. Global Age Related Macular Degeneration Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 19. Global Age Related Macular Degeneration Drug by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Age Related Macular Degeneration Drug as of 2021)
Table 20. Age Related Macular Degeneration Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Age Related Macular Degeneration Drug Product Type
Table 22. Date of International Manufacturers Enter into Age Related Macular Degeneration Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Regeneron Pharmaceuticals Corporation Information
Table 25. Regeneron Pharmaceuticals Description and Business Overview
Table 26. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 27. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product
Table 28. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Product in 2021
Table 29. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Application in 2021
Table 30. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2021
Table 31. Regeneron Pharmaceuticals Recent Development
Table 32. Bayer HealthCare Corporation Information
Table 33. Bayer HealthCare Description and Business Overview
Table 34. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 35. Bayer HealthCare Age Related Macular Degeneration Drug Product
Table 36. Bayer HealthCare Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Product in 2021
Table 37. Bayer HealthCare Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Application in 2021
Table 38. Bayer HealthCare Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2021
Table 39. Bayer HealthCare Recent Development
Table 40. Novartis Corporation Information
Table 41. Novartis Description and Business Overview
Table 42. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 43. Novartis Age Related Macular Degeneration Drug Product
Table 44. Novartis Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Product in 2021
Table 45. Novartis Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Application in 2021
Table 46. Novartis Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2021
Table 47. Novartis Recent Development
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 51. Roche Age Related Macular Degeneration Drug Product
Table 52. Roche Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Product in 2021
Table 53. Roche Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Application in 2021
Table 54. Roche Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2021
Table 55. Roche Recent Development
Table 56. Kanghong Pharma Corporation Information
Table 57. Kanghong Pharma Description and Business Overview
Table 58. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Kanghong Pharma Age Related Macular Degeneration Drug Product
Table 60. Kanghong Pharma Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Product in 2021
Table 61. Kanghong Pharma Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Application in 2021
Table 62. Kanghong Pharma Age Related Macular Degeneration Drug Sales Proportion of Age Related Macular Degeneration Drug by Geographic Area in 2021
Table 63. Kanghong Pharma Recent Development
Table 64. Global Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 65. Global Age Related Macular Degeneration Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 66. Global Age Related Macular Degeneration Drug Revenue by Type (2017-2022) & (US$ Million)
Table 67. Global Age Related Macular Degeneration Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 68. Global Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 69. Global Age Related Macular Degeneration Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 70. Global Age Related Macular Degeneration Drug Revenue by Application (2017-2022) & (US$ Million)
Table 71. Global Age Related Macular Degeneration Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 72. North America Age Related Macular Degeneration Drug Sales by Country (2017-2022) & (K Units)
Table 73. North America Age Related Macular Degeneration Drug Sales by Country (2023-2028) & (K Units)
Table 74. North America Age Related Macular Degeneration Drug Revenue by Country (2017-2022) & (US$ Million)
Table 75. North America Age Related Macular Degeneration Drug Revenue by Country (2023-2028) & (US$ Million)
Table 76. North America Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 77. North America Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 78. Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Age Related Macular Degeneration Drug Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Age Related Macular Degeneration Drug Revenue by Region (2017-2028) & (US$ Million)
Table 81. Asia-Pacific Age Related Macular Degeneration Drug Revenue by Region (2023-2028) & (US$ Million)
Table 82. Asia-Pacific Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 84. Europe Age Related Macular Degeneration Drug Sales by Country (2017-2022) & (K Units)
Table 85. Europe Age Related Macular Degeneration Drug Sales by Country (2023-2028) & (K Units)
Table 86. Europe Age Related Macular Degeneration Drug Revenue by Country (2017-2022) & (US$ Million)
Table 87. Europe Age Related Macular Degeneration Drug Revenue by Country (2023-2028) & (US$ Million)
Table 88. Europe Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 89. Europe Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 90. Latin America Age Related Macular Degeneration Drug Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Age Related Macular Degeneration Drug Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Age Related Macular Degeneration Drug Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Age Related Macular Degeneration Drug Revenue by Country (2023-2028) & (US$ Million)
Table 94. Latin America Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 95. Latin America Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 96. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2017-2022) & (K Units)
Table 97. Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2023-2028) & (K Units)
Table 98. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2017-2022) & (K Units)
Table 101. Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2017-2022) & (K Units)
Table 102. Age Related Macular Degeneration Drug Key Raw Materials, Industry Status and Trend
Table 103. Age Related Macular Degeneration Drug Key Raw Materials and Upstream Suppliers
Table 104. Age Related Macular Degeneration Drug Clients Status and Trend
Table 105. Age Related Macular Degeneration Drug Typical Clients
Table 106. Age Related Macular Degeneration Drug Distributors
Table 107. Age Related Macular Degeneration Drug Market Trends
Table 108. Age Related Macular Degeneration Drug Market Drivers
Table 109. Age Related Macular Degeneration Drug Market Challenges
Table 110. Age Related Macular Degeneration Drug Market Restraints
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Age Related Macular Degeneration Drug Product Picture
Figure 2. Global Age Related Macular Degeneration Drug Sales Market Share by Type in 2021 & 2028
Figure 3. Lucentis Product Picture
Figure 4. Eylea Product Picture
Figure 5. Avastin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Age Related Macular Degeneration Drug Sales Market Share by Application in 2021 & 2028
Figure 8. Hospitals Examples
Figure 9. Clinics Examples
Figure 10. Others Examples
Figure 11. Age Related Macular Degeneration Drug Report Years Considered
Figure 12. Global Age Related Macular Degeneration Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Age Related Macular Degeneration Drug Market Size 2017-2028 (US$ Million)
Figure 14. Global Age Related Macular Degeneration Drug Sales 2017-2028 (K Units)
Figure 15. Global Age Related Macular Degeneration Drug Market Size Market Share by Region: 2022 Versus 2028
Figure 16. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Region (2017-2028)
Figure 17. Global Age Related Macular Degeneration Drug Revenue Market Share by Region (2017-2028)
Figure 18. Global Age Related Macular Degeneration Drug Sales Share by Manufacturer in 2021
Figure 19. Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Type (2017-2028)
Figure 21. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Type (2017-2028)
Figure 22. Age Related Macular Degeneration Drug Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
Figure 23. Global Age Related Macular Degeneration Drug Sales Market Share Forecast by Application (2017-2028)
Figure 24. Global Age Related Macular Degeneration Drug Revenue Market Share Forecast by Application (2017-2028)
Figure 25. Age Related Macular Degeneration Drug Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
Figure 26. North America Age Related Macular Degeneration Drug Revenue 2017-2028 (US$ Million)
Figure 27. North America Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2022)
Figure 28. North America Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2022)
Figure 29. Asia-Pacific Age Related Macular Degeneration Drug Revenue 2017-2028 (US$ Million)
Figure 30. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Region (2017-2028)
Figure 31. Asia-Pacific Age Related Macular Degeneration Drug Revenue Market Share by Region (2017-2028)
Figure 32. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2022)
Figure 33. Asia-Pacific Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2022)
Figure 34. Europe Age Related Macular Degeneration Drug Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Europe Age Related Macular Degeneration Drug Sales Market Share by Country (2017-2028)
Figure 36. Europe Age Related Macular Degeneration Drug Revenue Market Share by Country (2017-2028)
Figure 37. Europe Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2022)
Figure 38. Europe Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2022)
Figure 39. Latin America Age Related Macular Degeneration Drug Revenue Growth Rate 2017-2028 (US$ Million)
Figure 40. Latin America Age Related Macular Degeneration Drug Sales Market Share by Country (2017-2028)
Figure 41. Latin America Age Related Macular Degeneration Drug Revenue Market Share by Country (2017-2022)
Figure 42. Latin America Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2022)
Figure 43. Latin America Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2022)
Figure 44. Middle East and Africa Age Related Macular Degeneration Drug Revenue Growth Rate 2017-2028 (US$ Million)
Figure 45. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Country (2017-2028)
Figure 46. Middle East and Africa Age Related Macular Degeneration Drug Revenue Market Share by Country (2017-2028)
Figure 47. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2022)
Figure 48. Middle East and Africa Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2022)
Figure 49. Age Related Macular Degeneration Drug Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Age Related Macular Degeneration Drug Raw Materials by Region in 2021
Figure 51. Age Related Macular Degeneration Drug Distribution Channels
Figure 52. Global Age Related Macular Degeneration Drug Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 53. Global Age Related Macular Degeneration Drug Percentage 2017-2028: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs